Reckitt to Pay $1.4 Billion to Settle U.S. Opioid-Addiction Drug Probes -- 2nd Update
July 11 2019 - 5:48AM
Dow Jones News
By Saabira Chaudhuri
LONDON -- Reckitt Benckiser Group PLC will pay up to $1.4
billion to settle U.S. investigations into whether its former
pharmaceuticals unit organized a multibillion-dollar fraud to drive
up sales of an opioid-addiction treatment.
The U.K. consumer-goods company -- which owns Lysol cleaner and
Durex condoms -- on Thursday said it struck a deal with the U.S.
Department of Justice and the Federal Trade Commission to resolve
their long-running investigations into the sales and marketing of
Suboxone Film.
Suboxone Film, a prescription medicine that dissolves in the
mouth, is made by Reckitt's former pharmaceuticals business,
Indivior, which became a stand-alone company in 2014. Suboxone,
whose active ingredient is an opioid, is used to treat addiction to
other drugs like heroin.
Federal prosecutors charged Indivior in April, saying that
starting in 2010 it "illegally obtained billions of dollars in
revenue" by deceiving health-care providers into believing that
Suboxone Film is safer and less susceptible to diversion and abuse
than similar drugs. The Justice Department is seeking at least $3
billion and control of other property from Indivior.
Indivior has denied the charges, saying it would vigorously
contest them and that the Justice Department is "fundamentally
wrong." A spokesman for the company didn't provide any updated
comment on Thursday.
The Justice Department's case against Indivior is separate from
the investigation into Reckitt. Analysts on Thursday reiterated
previous warnings that Indivior is unlikely to be able to afford a
large penalty, like the amount Reckitt agreed to pay.
Reckitt said it has "acted lawfully at all times and expressly
denies all allegations that it engaged in any wrongful conduct."
The company said it was settling to avoid the costs and distraction
of protracted litigation.
Reckitt has been working through a series of headwinds,
including a cyberattack, failed innovations and protests in South
Korea, where a humidifier disinfectant sold by the company killed
more than 100 people. Incoming Chief Executive Laxman Narasimhan,
formerly PepsiCo Inc.'s global chief commercial officer, is set to
take the reins in September.
Thursday's settlement protects Reckitt's participation in all
U.S. government programs, the company said, allaying some investor
fears that it could be barred from these. It also covers claims
relating to Medicaid programs for those states choosing to
participate in the settlement.
Shares in Reckitt rose 2.7% in morning trading in London. They
had tumbled in April after Indivior and the Justice Department
failed to reach an agreement.
Suboxone was approved by the Food and Drug Administration in
2002. It was the first narcotic drug doctors were able to prescribe
from their offices for opioid addiction but sales struggled after
the patent for the tablet version expired in 2010. At that point,
the company launched the Suboxone Film product and discontinued the
tablet in 2013.
The Justice Department charges outline Indivior's marketing plan
to transition patients from the tablet to the film. They say
Indivior falsely made safety claims about Suboxone Film and ran a
referral program to connect patients with doctors that Indivior
knew to be prescribing opioids in a "careless and clinically
unwarranted manner."
In recent years, the U.S. government has taken a more aggressive
approach to fighting the opioid crisis, with thousands of lawsuits
filed against opioid manufacturers and distributors. Nearly 218,000
people died in the U.S. from overdoses related to prescription
opioids between 1999 and 2017, according to federal data.
OxyContin maker Purdue Pharma LP -- controlled by members of the
billionaire Sackler family -- is weighing a bankruptcy filing as a
way to resolve the more than 1,600 lawsuits brought by states and
local municipalities accusing it and other companies of starting a
public-health crisis.
In 2017, President Trump declared the opioid crisis a public
health emergency and has taken steps to crack down on international
and domestic drug-supply chains.
--Adria Calatayud contributed to this article.
Write to Saabira Chaudhuri at saabira.chaudhuri@wsj.com
(END) Dow Jones Newswires
July 11, 2019 05:33 ET (09:33 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Reckitt Benckiser (LSE:RKT)
Historical Stock Chart
From Apr 2024 to May 2024
Reckitt Benckiser (LSE:RKT)
Historical Stock Chart
From May 2023 to May 2024